GO
Loading...

Drug Retail

More

  • BioMarin's CEO On Its Product Pipeline     Tuesday, 8 Jan 2013 | 2:20 PM ET

    The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.

  • Death of Gift Cards? Tuesday, 8 Jan 2013 | 2:09 PM ET
    Barnes & Noble gift cards

    Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.

  • Onyx CEO on Partnership With Bayer     Tuesday, 8 Jan 2013 | 1:22 PM ET

    Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.

  • NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.

  • Retail Sales Winners & Losers Thursday, 3 Jan 2013 | 12:27 PM ET
    Macy's shoppers

    The latest batch of retail sales reports shed light on who the retail winners are right now.

  • Antidepressants to Treat Grief?     Thursday, 27 Dec 2012 | 7:55 PM ET

    The American Psychiatric Association now says it's okay to use antidepressants for someone who is grieving over a recently lost loved one. Beverly Hills Psychiatrist Dr. Carole Lieberman, offers insight.

  • 'Pay For Delay' Case     Friday, 7 Dec 2012 | 7:25 PM ET

    The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.

  • Marijuana: Doobie Do's and Don'ts     Friday, 7 Dec 2012 | 2:50 PM ET

    CNBC's Jane Wells reports Washington's new state law that makes it legal to smoke pot, is more complicated than it sounds, and Allen St. Pierre, NORML executive director, weighs in on the financial benefits of reforming marijuana laws.

  • Some 150 workers at TriHealth, a Cincinnati-based health care company are unemployed today because they refused to get a free, company-sponsored flu shot. Michael Cannon, Cato Institute, thinks the company has a right to make this decision, while Barbara Fisher, National Vaccine Information Center, thinks this a violation of the workers' informed consent rights.

  • Liberals' Pipe Dream: A Nation of Stoners?     Thursday, 8 Nov 2012 | 7:52 PM ET

    Colorado and Washington made history on Tuesday becoming the first states to legalize the recreational use of marijuana. Janine Turner, Constituting America founder & co-chair, says "this is really disappointing, and stealing the promise of the future of America."

  • Can Statins Reduce Cancer Deaths?     Thursday, 8 Nov 2012 | 7:45 PM ET

    A new study out today in The New England Journal of Medicine finds statin use reduces the risk of death from cancer. Dr. Lori Mosca of New York Presbyterian Hospital and Columbia University Medical Center, offers insight on the drug and its side effects.

  • Marijuana Use Remains Against Federal Law     Thursday, 8 Nov 2012 | 2:45 PM ET

    The marijuana business is worth more than $300 billion worldwide, with CNBC's Brian Shactman & Brian Vicente, Campaign to Regulate Marijuana Like Alcohol.

  • NPS Pharmaceuticals CEO on Orphan Drugs     Wednesday, 24 Oct 2012 | 6:45 PM ET

    NPS Pharmaceuticals president & CEO Dr. Francois Nader, discusses strategies his company uses to finding value for shareholders, and appealing to the FDA.

  • Healthy Vitamin Stocks     Wednesday, 17 Oct 2012 | 2:37 PM ET

    Why vitamin stocks are moving higher, with CNBC's Seema Mody.

  • Deadly Meningitis Threat     Monday, 8 Oct 2012 | 7:22 PM ET

    NBC's Tom Costello reports on the outbreak of meningitis tied to a contaminated drug, saying as many as 13,000 people may have received one of the contaminated steroids.

  • Why Investors Like Pharma Stocks     Monday, 8 Oct 2012 | 2:23 PM ET

    Pharmaceuticals continue to be an attractive sector for earnings and dividend growth, and CNBC's Seema Mody reports on how companies like Pfizer are faring.

  • New Alzheimer's Data Shows Promise     Monday, 8 Oct 2012 | 1:16 PM ET

    Medical experts convening at the American Neurology Association meeting to evaluate phase 3 Alzheimer's data on a drug from Eli Lilly. CNBC's Seema Mody reports.

  • Lance Armstrong: Enough Is Enough     Friday, 24 Aug 2012 | 7:24 PM ET

    Lance Armstrong has announced he will no longer fight accusations that he used performance enhancing substances during his cycling career, with CNBC's Erin Sharoni.

  • The Economics of Pot Legalization     Thursday, 23 Aug 2012 | 4:39 PM ET

    One argument made in defense of legalizing pot is an economic one: a boost in revenue from taxes, lower cost in fighting the war on drugs, and even a solution to the nation's energy problem. Kevin Sabet, former White House Advisor on drug policy, and freelance journalist Doug Fine, discuss the war on drugs in the U.S. and the economics involved.

  • The Politics of Pot     Thursday, 23 Aug 2012 | 4:37 PM ET

    Could President Obama lose Colorado if he does not fix issues facing pot-related businesses? CNBC's Brian Shactman reports.